# Lercanidipine

## Zanidip 10mg

| TAH Drug Code      | [OZAN](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OZAN)                                                                                                                                                                                                                                                                                    |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of essential hypertension.                                                                                                                                                                                                                                                                                                                    |
| Dosing             | HTN: initial 10mg QD， May increase to 20 mg.                                                                                                                                                                                                                                                                                                           |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Patients with left ventricular outflow obstruction Untreated congestive heart failure Unstable angina or recent myocardial infarction (within 1 month) Severe hepatic impairment Severe renal impairment (GFR <30 ml/min)， including dialysis patients Avoid concurrent use with: Strong CYP3A4 inhibitors Cyclosporine Grapefruit or grapefruit juice |
| Adverse Effects    | Flushing， peripheral edema， palpitation， headache， dizziness.                                                                                                                                                                                                                                                                                       |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                 |
| More Info          | [UpToDate](https://www.uptodate.com/contents/lercanidipine-international-drug-information-concise)                                                                                                                                                                                                                                                      |

